417 related articles for article (PubMed ID: 27016260)
21. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
Boland JM; Maleszewski JJ; Wampfler JA; Voss JS; Kipp BR; Yang P; Yi ES
Hum Pathol; 2018 Jan; 71():8-19. PubMed ID: 28823574
[TBL] [Abstract][Full Text] [Related]
22. Postoperative survival of pulmonary invasive mucinous adenocarcinoma versus non-mucinous invasive adenocarcinoma.
Cui D; Xie S; Liu Q
BMC Pulm Med; 2023 Jan; 23(1):9. PubMed ID: 36624430
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W
World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008
[TBL] [Abstract][Full Text] [Related]
24. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
[TBL] [Abstract][Full Text] [Related]
26. [Construction of a Prognostic Prediction Model of Patients with Pathologic N0
in Resected Invasive Mucinous Adenocarcinoma of the Lung].
Wang Z; He J; Shen H; Chen X; Lin C; Yu H; Gao J; He X; Shen W
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):47-55. PubMed ID: 38296625
[TBL] [Abstract][Full Text] [Related]
27. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Impact of Histopathologic Features in Pulmonary Invasive Mucinous Adenocarcinomas.
Chang WC; Zhang YZ; Lim E; Nicholson AG
Am J Clin Pathol; 2020 Jun; 154(1):88-102. PubMed ID: 32215558
[TBL] [Abstract][Full Text] [Related]
29. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
[TBL] [Abstract][Full Text] [Related]
30. Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer.
Azari F; Kennedy G; Chang A; Nadeem B; Sullivan N; Marfatia I; Din A; Desphande C; Kucharczuk J; Delikatny EJ; Singhal S
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4406-4418. PubMed ID: 35876868
[TBL] [Abstract][Full Text] [Related]
31. EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-tyrosine kinase inhibitors in recurred cases.
Lee JS; Kim HR; Lee CY; Shin M; Shim HS
Ann Surg Oncol; 2013 Sep; 20(9):3015-22. PubMed ID: 23525704
[TBL] [Abstract][Full Text] [Related]
32. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.
Tsuta K; Kawago M; Inoue E; Yoshida A; Takahashi F; Sakurai H; Watanabe SI; Takeuchi M; Furuta K; Asamura H; Tsuda H
Lung Cancer; 2013 Sep; 81(3):371-376. PubMed ID: 23891509
[TBL] [Abstract][Full Text] [Related]
33. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
34. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
[TBL] [Abstract][Full Text] [Related]
35. Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
Lim JK; Shin KM; Lee HJ; Lee H; Hahm MH; Lee J; Kim CH; Cha SI; Jeong JY; Park TI
Acad Radiol; 2019 May; 26(5):e21-e31. PubMed ID: 30064921
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of the cribriform pattern in invasive adenocarcinoma of the lung.
Zhang R; Hu G; Qiu J; Wu H; Fu W; Feng Y; Zhang M; Chen C; Sun J; Zhang Y; Ren J
J Clin Pathol; 2019 Oct; 72(10):682-688. PubMed ID: 31253654
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma.
Gow CH; Hsieh MS; Liu YN; Lee YH; Shih JY
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439256
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
